A hospital laboratory is reviewing several distinct metabolic profiles of patients with di… — USMLE Step 3

A hospital laboratory is reviewing several distinct metabolic profiles of patients with disorders of calcium homeostasis. Match each patient's serum and urine biochemical profile to the most likely underlying pathophysiological mechanism.

Elevated serum $Ca^{2+}$ , decreased serum $PO_4^{3-}$ , elevated intact PTH, and elevated 24-hour urinary calciumAutonomous hormone secretion from a monoclonal chief cell adenoma
Decreased serum $Ca^{2+}$ , elevated serum $PO_4^{3-}$ , elevated intact PTH, and decreased 1,25-dihydroxycholecalciferolImpaired renal phosphate clearance and compromised 1-alpha-hydroxylase activity
Elevated serum $Ca^{2+}$ , high-normal intact PTH, and decreased fractional excretion of calcium (< 1%)Inactivating mutation of the G-protein coupled calcium-sensing receptor
Elevated serum $Ca^{2+}$ , high-normal serum $PO_4^{3-}$ , suppressed intact PTH, and elevated 1,25-dihydroxycholecalciferolEctopic, unregulated 1-alpha-hydroxylase activity by activated macrophages
Decreased serum $Ca^{2+}$ , elevated serum $PO_4^{3-}$ , suppressed intact PTH, and decreased 1,25-dihydroxycholecalciferolAcquired or autoimmune absence of functioning parathyroid glandular tissue

Answer

Profile 1 matches autonomous adenoma; Profile 2 matches impaired renal clearance; Profile 3 matches CaSR mutation; Profile 4 matches ectopic macrophage activity; Profile 5 matches absent parathyroid tissue.

Each laboratory profile uniquely matches a specific pathophysiological lesion. The interplay between calcium, phosphorus, PTH, and vitamin D allows for precise localization of the defect to the parathyroid glands, kidneys, calcium-sensing receptors, or ectopic sources.

Step-by-Step Solution

Analyze the parathyroid hormone (PTH) levels relative to the serum calcium levels.

In profiles 1, 3, and 4, hypercalcemia is present. In profiles 2 and 5, hypocalcemia is present.

Determining whether PTH is appropriately suppressed or inappropriately elevated helps distinguish parathyroid-dependent from parathyroid-independent mechanisms.

Evaluate hypercalcemic profiles (1, 3, 4).

Profile 1 has high PTH and high urine calcium (Primary hyperparathyroidism). Profile 3 has normal/high PTH and low urine calcium (FHH). Profile 4 has suppressed PTH and high active vitamin D (Granulomatous disease).

Urinary calcium and vitamin D levels differentiate the underlying causes of hypercalcemia.

Evaluate hypocalcemic profiles (2, 5).

Profile 2 has elevated PTH (Secondary hyperparathyroidism due to CKD). Profile 5 has suppressed PTH (Primary hypoparathyroidism).

The PTH response defines whether the defect is in the parathyroid glands themselves or due to chronic end-organ dysfunction.

Key Concept

Differential diagnosis of calcium and phosphate homeostasis disorders based on the parathyroid hormone, 1,25-dihydroxyvitamin D, and urinary calcium axes.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic